# NextTrip, Inc.: financial statements, quarterly

NTRP · Nasdaq · CIK 788611 · [Industrials](/sectors/industrials.md) · fiscal year ends Feb 28

Pages: [Overview](/companies/ntrp.md) · [Financials](/companies/ntrp/financials.md) · [Filings](/companies/ntrp/filings.md) · [Insiders](/companies/ntrp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ntrp/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-11-30) | Q4 FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [206](/filings/0001493152-25-002136.md) | [206 d](/filings/0001641172-25-012889.md) | [189](/filings/0001641172-25-019738.md) | [154](/filings/0001493152-25-018172.md) | [74.6](/filings/0001493152-26-002276.md) | [83.5 d](/filings/0001493152-26-026334.md) | [139](/filings/0001493152-26-033385.md) | [758](/filings/0001437749-26-032722.md) | [1,200](/filings/0001493152-26-002276.md) | [1,619 d](/filings/0001493152-26-026334.md) | [1,452](/filings/0001493152-26-033385.md) | [547](/filings/0001437749-26-032722.md) |
| Cost of revenue | $k | [162](/filings/0001493152-25-002136.md) | [194 d](/filings/0001641172-25-012889.md) | [174](/filings/0001641172-25-019738.md) | [155](/filings/0001493152-25-018172.md) | [76.8](/filings/0001493152-26-002276.md) | [92.3 d](/filings/0001493152-26-026334.md) | [99.9](/filings/0001493152-26-033385.md) | [592](/filings/0001493152-25-018172.md) | [983](/filings/0001493152-26-002276.md) | [1,388 d](/filings/0001493152-26-026334.md) | [1,244](/filings/0001493152-26-033385.md) | not reported |
| Gross profit | $k | [43.7](/filings/0001493152-25-002136.md) | [11.7 d](/filings/0001641172-25-012889.md) | [15.2](/filings/0001641172-25-019738.md) | [(1.0)](/filings/0001493152-25-018172.md) | [(2.1)](/filings/0001493152-26-002276.md) | [(8.8) d](/filings/0001493152-26-026334.md) | [38.9](/filings/0001493152-26-033385.md) | [166](/filings/0001437749-26-032722.md) | [217](/filings/0001493152-26-002276.md) | [231 d](/filings/0001493152-26-026334.md) | [208](/filings/0001493152-26-033385.md) | [176](/filings/0001437749-26-032722.md) |
| Research and development | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $k | [(1,231)](/filings/0001493152-25-002136.md) | [(2,331) d](/filings/0001641172-25-012889.md) | [(1,952)](/filings/0001641172-25-019738.md) | [(1,469)](/filings/0001493152-25-018172.md) | [(1,774)](/filings/0001493152-26-002276.md) | [(2,218) d](/filings/0001493152-26-026334.md) | [(4,640)](/filings/0001493152-26-033385.md) | [(3,203)](/filings/0001437749-26-032722.md) | [(3,085)](/filings/0001493152-26-002276.md) | [(5,438) d](/filings/0001493152-26-026334.md) | [(2,914)](/filings/0001493152-26-033385.md) | [(3,317)](/filings/0001437749-26-032722.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001437749-26-032722.md) | not reported | not reported | not reported | [0.0](/filings/0001437749-26-032722.md) |
| Net income | $k | [(1,308)](/filings/0001493152-25-002136.md) | [(3,768) d](/filings/0001641172-25-012889.md) | [(1,979)](/filings/0001641172-25-019738.md) | [(1,535)](/filings/0001493152-25-018172.md) | [(2,009)](/filings/0001493152-26-002276.md) | [(4,597) d](/filings/0001493152-26-026334.md) | [(4,457)](/filings/0001493152-26-033385.md) | [(2,898)](/filings/0001437749-26-032722.md) | [(3,276)](/filings/0001493152-26-002276.md) | [(5,281) d](/filings/0001493152-26-026334.md) | [(3,125)](/filings/0001493152-26-033385.md) | [(3,724)](/filings/0001437749-26-032722.md) |
| Diluted EPS | $ per share | [(15.69)](/filings/0001493152-25-002136.md) | not reported | [(1.55)](/filings/0001641172-25-019738.md) | [(1.14)](/filings/0001493152-25-018172.md) | [(0.35)](/filings/0001493152-26-002276.md) | not reported | [(0.68)](/filings/0001493152-26-033385.md) | [(0.39)](/filings/0001493152-25-018172.md) | [(0.37)](/filings/0001493152-26-002276.md) | not reported | [(0.22)](/filings/0001493152-26-033385.md) | not reported |
| Basic EPS | $ per share | [(15.69)](/filings/0001493152-25-002136.md) | not reported | [(1.55)](/filings/0001641172-25-019738.md) | [(1.14)](/filings/0001493152-25-018172.md) | [(0.35)](/filings/0001493152-26-002276.md) | not reported | [(0.68)](/filings/0001493152-26-033385.md) | [(0.39)](/filings/0001437749-26-032722.md) | [(0.37)](/filings/0001493152-26-002276.md) | not reported | [(0.22)](/filings/0001493152-26-033385.md) | [(0.25)](/filings/0001437749-26-032722.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-11-30) | FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.3](/filings/0001641172-25-012889.md) | [0.0](/filings/0001493152-24-036417.md) | [0.1](/filings/0001493152-24-041139.md) | [0.0](/filings/0001493152-25-002136.md) | [1.1](/filings/0001493152-26-026334.md) | [0.1](/filings/0001641172-25-019738.md) | [1.8](/filings/0001493152-25-018172.md) | [2.4](/filings/0001493152-26-002276.md) | [1.7](/filings/0001437749-26-032722.md) | [0.8](/filings/0001493152-26-033385.md) | [1.1](/filings/0001437749-26-032722.md) |
| Current assets | $m | not reported | [1.7](/filings/0001641172-25-012889.md) | [1.4](/filings/0001493152-24-036417.md) | [1.4](/filings/0001493152-24-041139.md) | [1.5](/filings/0001493152-25-002136.md) | [2.5](/filings/0001493152-26-026334.md) | [1.6](/filings/0001641172-25-019738.md) | [3.5](/filings/0001493152-25-018172.md) | [4.3](/filings/0001493152-26-002276.md) | [3.2](/filings/0001437749-26-032722.md) | [2.5](/filings/0001493152-26-033385.md) | [3.0](/filings/0001437749-26-032722.md) |
| Total assets | $m | not reported | [5.1](/filings/0001641172-25-012889.md) | [4.7](/filings/0001493152-24-036417.md) | [4.9](/filings/0001493152-24-041139.md) | [5.0](/filings/0001493152-25-002136.md) | [9.9](/filings/0001493152-26-026334.md) | [11.0](/filings/0001641172-25-019738.md) | [13.9](/filings/0001493152-25-018172.md) | [14.4](/filings/0001493152-26-002276.md) | [13.1](/filings/0001437749-26-032722.md) | [12.3](/filings/0001493152-26-033385.md) | [12.8](/filings/0001437749-26-032722.md) |
| Current liabilities | $m | not reported | [2.0](/filings/0001641172-25-012889.md) | [3.5](/filings/0001493152-24-036417.md) | [5.0](/filings/0001493152-24-041139.md) | [6.4](/filings/0001493152-25-002136.md) | [2.6](/filings/0001493152-26-026334.md) | [2.7](/filings/0001641172-25-019738.md) | [5.0](/filings/0001493152-25-018172.md) | [5.1](/filings/0001493152-26-002276.md) | [3.9](/filings/0001437749-26-032722.md) | [4.1](/filings/0001493152-26-033385.md) | [6.2](/filings/0001437749-26-032722.md) |
| Total liabilities | $m | not reported | [2.0](/filings/0001641172-25-012889.md) | [3.5](/filings/0001493152-24-036417.md) | [5.0](/filings/0001493152-24-041139.md) | [6.4](/filings/0001493152-25-002136.md) | [2.6](/filings/0001493152-26-026334.md) | [4.3](/filings/0001641172-25-019738.md) | [7.9](/filings/0001493152-25-018172.md) | [8.1](/filings/0001493152-26-002276.md) | [7.3](/filings/0001437749-26-032722.md) | [7.4](/filings/0001493152-26-033385.md) | [8.0](/filings/0001437749-26-032722.md) |
| Shareholders' equity | $m | [(3.1)](/filings/0001493152-25-002136.md) | [3.1](/filings/0001493152-26-026334.md) | [1.2](/filings/0001493152-25-018172.md) | [(0.1)](/filings/0001493152-26-002276.md) | [(1.4)](/filings/0001493152-26-002276.md) | [7.4](/filings/0001437749-26-032722.md) | [6.7](/filings/0001437749-26-032722.md) | [5.6](/filings/0001437749-26-032722.md) | [5.9](/filings/0001493152-26-002276.md) | [5.4](/filings/0001437749-26-032722.md) | [3.7](/filings/0001437749-26-032722.md) | [4.8](/filings/0001437749-26-032722.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-11-30) | Q4 FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(872) d](/filings/0001493152-25-002136.md) | [(3,466) d](/filings/0001641172-25-012889.md) | [(1,142)](/filings/0001641172-25-019738.md) | [(810) d](/filings/0001493152-25-018172.md) | [(1,183) d](/filings/0001493152-26-002276.md) | [(1,945) d](/filings/0001493152-26-026334.md) | [(1,043)](/filings/0001493152-26-033385.md) | [572 d](/filings/0001437749-26-032722.md) | [(1,981) d](/filings/0001493152-26-002276.md) | [(2,111) d](/filings/0001493152-26-026334.md) | [(2,343)](/filings/0001493152-26-033385.md) | [(2,460) d](/filings/0001437749-26-032722.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Share repurchases: not reported

## Shares

| Line item | Unit | period not labelled (2023-05-31) | Q2 FY2024 (2023-06-30) | period not labelled (2023-08-31) | Q3 FY2024 (2023-09-30) | period not labelled (2023-11-30) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q1 FY2027 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.1](/filings/0001493152-24-036417.md) | [10.8](/filings/0001493152-23-028422.md) | [0.1](/filings/0001493152-24-041139.md) | [0.6](/filings/0001493152-23-040485.md) | [0.1](/filings/0001493152-25-002136.md) | [1.3](/filings/0001641172-25-019738.md) | [1.4](/filings/0001493152-25-018172.md) | [5.8](/filings/0001493152-26-002276.md) | [6.6](/filings/0001493152-26-033385.md) | [7.9](/filings/0001493152-25-018172.md) | [9.0](/filings/0001493152-26-002276.md) | [14.3](/filings/0001493152-26-033385.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 15,229,900 at 2026-10-14, from the cover of the [10-Q filed 2026-10-15](/filings/0001437749-26-032722.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.